Latest On Olympus Corporation (OCPNY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-01-12 16:45 EST | News | Olympus says addressing FDA concerns on endoscope production | N/A |  |
| 2022-11-12 14:54 EST | News | Olympus Corporation (OCPNY) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-12 14:54 EST | News | Olympus Corporation 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-11 21:02 EST | News | Olympus Corporation reports FQ2 results | N/A | |
| 2022-08-23 20:43 EST | News | Olympus nearing deal to divest microscope unit for $2.2B, say sources | N/A | |
| 2022-08-10 08:52 EST | News | Olympus Corporation GAAP EPS of ¥19.52, revenue of ¥214.06B | N/A | |
| 2022-08-10 08:52 EST | News | Olympus Corporation (OCPNY) Management on Q1 2023 Results - Earnings Call Transcript | N/A | |
| 2022-08-10 08:52 EST | News | Olympus Corporation 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-11-06 12:29 EST | News | Olympus Corp Brands, Inc. (OCPNF) on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2021-08-07 10:40 EST | News | Olympus Corporation (OCPNY) Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2021-08-07 10:40 EST | News | Olympus Corporation 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-07-22 12:19 EST | News | Olympus: Medtech With Optimized Portfolio And Predictable Earnings Growth | N/A | |
| 2021-02-15 12:54 EST | Analyst Rating | The Analyst Target Price has increased from $23.8 to $26.7. | Buy | |
| 2021-02-13 21:09 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-13 04:14 EST | News | Olympus Corporation 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-02-13 04:14 EST | News | Olympus Corp (OCPNF) Management on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2020-11-26 22:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 06:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-14 16:36 EST | News | Olympus Corp (OCPNF) on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2020-11-13 15:40 EST | News | Olympus Corporation 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-11-08 01:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 14:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 10:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-08 07:12 EST | News | Olympus Corporation (OCPNF) Management on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2020-08-07 14:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 04:37 EST | News | Olympus Corporation 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-07-30 18:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-07 06:12 EST | Analyst Rating | The Analyst Target Price has increased from $22.9 to $23.8. | Buy | |
| 2020-07-01 18:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-05 14:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-04 10:06 EST | Analyst Rating | The Analyst Target Price has increased from $20 to $22.9. | Buy | |
| 2020-06-02 06:32 EST | Analyst Rating | The Analyst Target Price has increased from $19 to $20. | Buy | |
| 2020-05-30 02:03 EST | News | Olympus Corporation 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2020-05-30 02:03 EST | News | Olympus' (OCPNF) Management on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2020-05-27 07:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:19 EST | Financials | Company financials have been released. | Neutral | |
About Olympus Corporation (OCPNY):
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through five segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, Imaging Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, video and other endoscopes system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Imaging Business segment provides digital cameras, IC and voice recorders, mirrorless interchangeable-lens cameras, and interchangeable lenses. The Others segment offers biomedical materials. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and GI- and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
General
- Name Olympus Corporation
- Symbol OCPNY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 35,174
- Last Split Factor4:1
- Last Split Date2019-04-09
- Fiscal Year EndMarch
- Web URLhttp://www.olympus-global.com
View More
Valuation
- Trailing PE 37.65
- Forward PE 36.23
- Price/Sales (Trailing 12 Mt.) 4.12
- Price/Book (Most Recent Quarter) 8.7
- Enterprise Value Revenue 0.04
- Enterprise Value EBITDA 0.23
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin -1%
- Return on Assets 5%
- Return on Equity 12%
- Earnings Per Share $0.58
- Revenue Per Share $0
- Gross Profit 499.57 billion
- Quarterly Earnings Growth -4.3%
View More
Highlights
- Market Capitalization 27.79 billion
- PE Ratio 24.78
- Analyst Target Price $26.7
- Book Value Per Share $11.74
View More
Share Statistics
- Shares Outstanding 1.29 billion
- Shares Float 1.29 billion
- % Held by Insiders <1%
- % Held by Institutions 0.11%
View More
Technicals
- Beta 0.87
- 52 Week High $22.99
- 52 Week Low $11.09
- 50 Day Moving Average 20.83
- 200 Day Moving Average 20.61
View More
Dividends
- Forward Annual Dividend Rate $0.1
- Forward Annual Dividend Yield 0.43%
- Payout Ratio 16%
- Dividend Date 2017-07-10
- ExDividend Date 2020-05-28
- Dividend Per Share $0.25
- Dividend Yield 0%
View More
Olympus Corporation (OCPNY) Dividend Calendar:
OCPNY's last dividend payment was made to shareholders on July 10, 2017.
Olympus Corporation pays out 16% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Olympus Corporation (OCPNY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-15 | $N/A | $0.18 | ||
| 2020-09-30 | 2020-12-31 | $179.85 billion | $0.21 | ||
| 2020-06-30 | 2020-09-30 | $142.4 billion | $0.19 | ||
| 2020-03-31 | 2020-06-30 | $N/A | $-0.00 | ||
| 2019-12-31 | 2020-03-31 | $1.9 billion | -$0.05 | ||
| 2019-09-30 | 2019-12-31 | $1.92 billion | $0.17 | ||
| 2019-06-30 | 2019-09-30 | $1.68 billion | $0.19 | ||
| 2019-03-31 | 2019-06-30 | $1.91 billion | $0.06 | ||
| 2018-12-31 | 2019-03-31 | $1.82 billion | $0.01 | ||
| 2018-09-30 | 2018-12-31 | $1.77 billion | $0.08 | ||
| 2018-06-30 | 2018-09-30 | $1.63 billion | $0.07 | ||
| 2018-03-31 | 2018-06-30 | $2.02 billion | -$0.11 | ||
| 2017-12-31 | 2018-03-31 | $1.8 billion | $0.06 | ||
| 2017-09-30 | 2017-12-31 | $1.75 billion | $0.12 | ||
| 2017-06-30 | 2017-09-30 | $171.85 billion | $0.13 | ||
| 2017-03-31 | 2017-06-30 | $214.54 billion | $0.07 | ||
| 2016-12-31 | 2017-03-31 | $183.53 billion | $0.24 | ||
| 2016-09-30 | 2016-12-31 | $0.12 | |||
| 2016-06-30 | 2016-09-30 | $0.10 | |||
| 2016-03-31 | 2016-06-30 | $0.06 | |||
| 2015-12-31 | 2016-03-31 | $0.13 | |||
| 2015-09-30 | 2015-12-31 | $0.04 | |||
| 2015-06-30 | 2015-09-30 | $0.12 | |||
| 2015-03-31 | 2015-06-30 | $0.10 | |||
| 2014-12-31 | 2015-03-31 | -$0.25 | |||
| 2014-09-30 | 2014-12-31 | $0.06 | |||
| 2014-06-30 | 2014-09-30 | $0.09 | |||
| 2014-03-31 | 2014-06-30 | $0.06 | |||
| 2013-12-31 | 2014-03-31 | $0.06 | |||
| 2013-09-30 | 2013-12-31 | $0.10 | |||
| 2013-06-30 | 2013-09-30 | -$0.05 | |||
| 2013-03-31 | 2013-06-30 | -$0.02 | |||
| 2012-12-31 | 2013-03-31 | $0.00 | |||
| 2012-09-30 | 2012-12-31 | $-0.00 | |||
| 2012-06-30 | 2012-09-30 | $0.15 | |||
| 2012-03-31 | 2012-06-30 | -$0.05 | |||
| 2011-12-31 | 2012-03-31 | -$0.18 | |||
| 2011-09-30 | 2011-12-31 | -$0.01 | |||
| 2011-06-30 | 2011-09-30 | -$0.38 | |||
| 2011-03-31 | 2011-06-30 | -$0.02 | |||
| 2010-12-31 | 2011-03-31 | -$0.05 | |||
| 2010-09-30 | 2010-12-31 | $0.02 | |||
| 2010-06-30 | 2010-08-05 | $0.02 | |||
| 2010-03-31 | 2010-05-11 | $0.04 | |||
| 2009-12-31 | 2010-02-10 | $0.08 | |||
| 2009-09-30 | 2009-11-06 | $0.34 | |||
| 2009-06-30 | 2009-08-06 | $0.02 | |||
| 2009-03-31 | 2009-05-12 | -$0.86 | |||
| 2008-06-30 | 2008-08-01 | $0.06 | |||
| 2008-03-31 | 2008-05-09 | $0.06 |
Olympus Corporation (OCPNY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | 25.64 billion | 209 million | N/A | 235.88 million |
| Selling General Administrative | N/A | 81.13 billion | 84.63 billion | N/A | 917.4 million |
| Gross Profit | N/A | 110.71 billion | 87.25 billion | N/A | 1.2 billion |
| Ebit | N/A | 40.54 billion | 16.91 billion | N/A | 252.16 million |
| Operating Income | N/A | 26.53 billion | 1.16 billion | N/A | 252.16 million |
| Income Tax Expense | 5.53 billion | N/A | 2.94 billion | 11.09 billion | 23.43 million |
| Total Revenue | N/A | 179.85 billion | 142.4 billion | N/A | 1.9 billion |
| Cost of Revenue | N/A | 69.14 billion | 55.15 billion | N/A | 695.94 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -16.29 million |
| Net Income From Continuing Operations | N/A | 26.05 billion | -2.73 billion | N/A | 212.45 million |
| Net Income Applicable to Common Shares | 24.33 billion | N/A | -2.74 billion | -7.47 billion | 212.43 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -57.92 billion | -12.29 billion | N/A | 15.35 million | 555144.34 |
| Change to Liabilities | N/A | -10.09 billion | 3.93 billion | 15.39 million | -8.23 million |
| Total Cash Flow from Investing Activities | N/A | -12.29 billion | -17.39 billion | -125.42 million | -147.11 million |
| Net Borrowings | N/A | 115.31 billion | 10.31 billion | -140.14 million | 924.8 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -169.69 million | 7.01 million |
| Change to Operating Activities | N/A | -7.8 billion | 15.18 billion | 12.46 million | -2.29 million |
| Change in Cash | -60.13 billion | 107.95 billion | N/A | 85.69 million | 201.61 million |
| Total Cash from Operating Activities | 29.06 billion | 8.39 billion | 27.81 billion | 354.14 million | 359.59 million |
| Depreciation | 13.77 billion | 15.38 billion | N/A | 157.66 million | 147.77 million |
| Other Cash Flow from Investing Activities | N/A | 238 million | 341 million | -2.61 million | -3.07 million |
| Change to Inventory | 7.47 billion | -15.2 billion | N/A | -32.64 million | -5.88 million |
| Change to Account Receivables | N/A | N/A | N/A | 15.93 million | -74.54 million |
| Other Cash Flow from Financing Activities | N/A | -3.49 billion | -806 million | -29.55 million | -53.79 million |
| Change to Net Income | N/A | -5.68 billion | 9.95 billion | -50.52 million | -20.73 million |
| Capital Expenditures | 13.57 billion | 12.64 billion | N/A | 71.13 million | 90.64 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 745.96 billion | 737.13 billion | N/A | 5.44 billion |
| Total Stockholder Equity | N/A | 326.52 billion | 360.91 billion | N/A | 3.65 billion |
| Other Current Liabilities | 221.83 billion | 124.09 billion | 127.91 billion | N/A | 1.52 billion |
| Total Assets | N/A | 1.07 trillion | 1.1 trillion | N/A | 9.09 billion |
| Common Stock | 124.64 billion | 124.64 billion | 124.64 billion | 124.64 billion | 1.15 billion |
| Other Current Assets | 44.04 billion | 17.85 billion | 25.7 billion | N/A | 246.45 million |
| Retained Earnings | 258.74 billion | 230.94 billion | 264.49 billion | 275.83 billion | 2.65 billion |
| Other Liabilities | 120.59 billion | 108.85 billion | 112.83 billion | 110.04 billion | 947.54 million |
| Other Assets | 98.21 billion | 92.42 billion | 49.75 billion | 104.17 billion | 396.42 million |
| Cash | N/A | 185.62 billion | 270.51 billion | N/A | 1.33 billion |
| Total Current Liabilities | 295.62 billion | 303.61 billion | 344.41 billion | N/A | 2.55 billion |
| Other Stockholder Equity | -21.78 billion | -22.16 billion | -21.25 billion | -22.75 billion | -82.26 million |
| Property, Plant & Equipment | 207.64 billion | 199.79 billion | 201.3 billion | 202.13 billion | 1.89 billion |
| Total Current Assets | 553.94 billion | 571.17 billion | 604.4 billion | N/A | 4.45 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | 789.21 million |
| Net Tangible Assets | 142.98 billion | 150.57 billion | 188.42 billion | 197.63 billion | 2.08 billion |
| Short Term Investments | N/A | 42.77 billion | 2.37 billion | N/A | N/A |
| Long Term Debt | N/A | 333.49 billion | 283.98 billion | N/A | 1.94 billion |
| Inventory | 159.46 billion | 160.86 billion | 183.32 billion | N/A | 1.55 billion |
| Accounts Payable | 47.47 billion | 44.37 billion | 47.87 billion | N/A | 507.1 million |
Olympus Corporation (OCPNY) Chart:
Olympus Corporation (OCPNY) News:
Below you will find a list of latest news for Olympus Corporation (OCPNY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Olympus Corporation (OCPNY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Olympus Corporation (OCPNY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|